Ethyl 5-amino-1-(4-nitrophenyl)-1H-pyrazole-4-carboxylate, 95.0%, 10g

1-((2,5-dimethylphenyl)sulfonamido)cyclohexane-1-carboxylic acid, 95.0%, 1g

H-stand, 1 Piece

2-(Benzyloxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95.0%, 250mg

2-Bromo-4-nitro(trifluoromethoxy)benzene, 97.0%, 5g

N,N-Dimethylglycine hydrochloride, 95.0%, 100g

4-OXA-7-AZASPIRO[2.5]OCTAN-6-ONE, 95.0%, 250mg

3-Bromophenylboronic acid, 98.0%, 10g

n-(2-Morpholinoethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 97%, 1g

N-Benzyliminodiacetic acid, 95.0%, 5g

1,1,3-Trimethylurea, 95%, 25g

G2 2AB (500pmol/vial)1vial

3-(2-Trifluoromethyl-phenyl)-acryloyl chloride, 1g